Dentsply International Inc. (NASDAQ:XRAY) – Equities researchers at William Blair decreased their Q4 2016 EPS estimates for shares of Dentsply International in a research report issued to clients and investors on Monday. William Blair analyst J. Kreger now anticipates that the brokerage will post earnings of $0.63 per share for the quarter, down from their previous estimate of $0.66. William Blair also issued estimates for Dentsply International’s FY2017 earnings at $3.07 EPS, FY2018 earnings at $3.47 EPS and FY2019 earnings at $3.81 EPS.

Several other equities research analysts have also recently issued reports on XRAY. Credit Suisse Group AG restated a “buy” rating on shares of Dentsply International in a report on Sunday, June 26th. JPMorgan Chase & Co. began coverage on shares of Dentsply International in a research note on Thursday, September 22nd. They set a “neutral” rating and a $65.00 price target on the stock. Zacks Investment Research cut shares of Dentsply International from a “buy” rating to a “hold” rating in a research note on Monday, August 8th. Piper Jaffray Cos. reiterated a “buy” rating on shares of Dentsply International in a research note on Monday, June 27th. Finally, Barrington Research cut shares of Dentsply International from an “outperform” rating to a “market perform” rating in a research note on Monday, August 8th. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $66.91.

Earnings History and Estimates for Dentsply International (NASDAQ:XRAY)

Shares of Dentsply International (NASDAQ:XRAY) opened at 57.82 on Wednesday. The company has a 50 day moving average of $59.86 and a 200-day moving average of $61.32. Dentsply International has a 12-month low of $53.43 and a 12-month high of $65.83.

Dentsply International (NASDAQ:XRAY) last announced its earnings results on Friday, August 5th. The company reported $0.76 earnings per share for the quarter, topping analysts’ consensus estimates of $0.70 by $0.06. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. Dentsply International had a return on equity of 9.18% and a net margin of 11.99%. The company’s revenue was up 46.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.73 EPS.

The business also recently declared a dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be issued a $0.0775 dividend. The ex-dividend date of this dividend is Wednesday, September 28th. Dentsply International’s dividend payout ratio is currently 14.49%.

In other Dentsply International news, VP Rainer Berthan sold 5,000 shares of Dentsply International stock in a transaction on Tuesday, September 6th. The shares were sold at an average price of $61.12, for a total value of $305,600.00. Following the sale, the vice president now directly owns 34,370 shares in the company, valued at approximately $2,100,694.40. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Maureen J. Macinnis sold 45,100 shares of Dentsply International stock in a transaction on Thursday, August 25th. The shares were sold at an average price of $60.55, for a total transaction of $2,730,805.00. Following the completion of the sale, the senior vice president now owns 36,730 shares in the company, valued at $2,224,001.50. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

A number of hedge funds have recently made changes to their positions in the stock. Checchi Capital Advisers LLC increased its stake in Dentsply International by 2.1% in the second quarter. Checchi Capital Advisers LLC now owns 2,007 shares of the company’s stock worth $125,000 after buying an additional 41 shares during the period. Contravisory Investment Management Inc. increased its stake in Dentsply International by 8.9% in the third quarter. Contravisory Investment Management Inc. now owns 3,108 shares of the company’s stock worth $185,000 after buying an additional 254 shares during the period. Global X Management Co. LLC increased its stake in Dentsply International by 110.1% in the second quarter. Global X Management Co. LLC now owns 3,169 shares of the company’s stock worth $197,000 after buying an additional 1,661 shares during the period. Evercore Wealth Management LLC increased its stake in Dentsply International by 12.6% in the second quarter. Evercore Wealth Management LLC now owns 3,204 shares of the company’s stock worth $199,000 after buying an additional 358 shares during the period. Finally, Mizuho Asset Management Co. Ltd. increased its stake in Dentsply International by 170.4% in the second quarter. Mizuho Asset Management Co. Ltd. now owns 3,228 shares of the company’s stock worth $200,000 after buying an additional 2,034 shares during the period. Institutional investors own 94.58% of the company’s stock.

Dentsply International Company Profile

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Receive News & Stock Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related stocks with our FREE daily email newsletter.